Dr. Deborah Meyran is an early-career clinician-scientist, serving as a paediatric oncologist at the Royal Children’s Hospital (RCH) and a post-doctoral researcher in the Cancer Immunology Program at Peter MacCallum Cancer Centre (PMCC) and the Murdoch Children’s Research Institute (MCRI). She is also an Academic Senior Fellow in the Department of Paediatrics at the University of Melbourne.

Dr. Meyran established Australia’s first immune profiling platform for paediatric tumours in collaboration with the Zero Childhood Cancer Program, launching key studies on aggressive cancers such as paediatric brain tumours, osteosarcoma, and neuroblastoma. She is a chief or associate investigator on 12 projects in immune profiling and immunotherapy across PMCC, the Children’s Cancer Institute (CCI), RCH, and the Victorian Paediatric Cancer Consortium (VPCC). She leads the PMCC-RCH-MCRI-CCI collaboration on T cell-based immunotherapy, with a focus on developing memory CAR T cells for paediatric cancers.

Recognized as an emerging leader in paediatric immunotherapy, Dr. Meyran has been invited to present at 25+ international and national conferences and has published her work in high-impact factor journals such as Science Translational Medicine, Annals of Oncology, Cancer Discovery. She is also a peer reviewer for leading journals and has received multiple awards, including the Picchi Award for Excellence in Cancer Research (2020). Her research program has secured >$6M AUD in funding from NHMRC, Cancer Australia, European agencies, and philanthropic sources to advance personalized immunotherapy for children with cancer.